These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Author: Bönner G, Fuchs W.
    Journal: Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893.
    Abstract:
    Candesartan cilexetil is a highly potent and long-acting angiotensin II type I (AT1) receptor antagonist. This short review summarises results of clinical studies focusing on the duration of action of candesartan cilexetil. Results of previous clinical studies indicate that candesartan has the property to maintain a sustained blood pressure reduction for up to 48 h after dosing. Since lack of compliance is a known problem in patients with hypertension, these findings could be of particular clinical relevance.
    [Abstract] [Full Text] [Related] [New Search]